To Top

Content Filter


2645 Articles available
Acquisition

Therapix Biosciences Provides Update Regarding FSD Acquisition

PR-M12-18-NI-052
Presentation

Abbott to Present at J.P. Morgan Healthcare Conference

PR-M12-18-NI-051
Appointment

BiomX Appoints Sailaja Puttagunta as Chief Medical Officer

PR-M12-18-NI-048
FDA

XOSPATA® (gilteritinib) Available at Biologics by McKesson

PR-M12-18-NI-045
Pricing

Tenax Therapeutics Announces Pricing of $10 Million Underwritten Offering

Expansion

NYCEDC Grants $1M To Quentis Therapeutics For Expansion of LifeSci Space in West Harlem

PR-M12-18-NI-043
Financing

Impel NeuroPharma Closes $67.5 Million Series D Financing

PR-M12-18-NI-040
Immuno-Oncology

Immuno-oncology Development Trends and Opportunities

PR-M12-18-NI-038
Alzheimer's Disease

First Drug Candidate From Eisai-UCL Research Collaboration To Enter Alzheimer's Disease Clinical Trials

PR-M12-18-NI-037
Financial Results

Amgen Announces 10 Percent Increase In 2019 First Quarter Dividend

PR-M12-18-NI-036
Approval

Genentech Receives Additional Approval for Tecentriq

PAO-M12-18-NI-011
Appointment

Roche Exec Moves to Gilead

PAO-M12-18-NI-010
FDA

FDA Issues Draft Guidance for Companion Diagnostics

PAO-M12-18-NI-009
Spin-off Business

Mallinckrodt Spins off its Generics Business

PAO-M12-18-NI-005-11
Growth

WuXi AppTec Plans for Growth

PAO-M12-18-NI-005-10
Expansion

Investor Group Purchases 110-Acre Pharmaceutical Campus in Huntsville, Alabama

PR-M12-18-NI-047
M&A

Histo-Scientific Research Laboratories and Vet Path Services Merge

PR-M12-18-NI-046
Gene and Cell Therapy

PPD Expands GMP Lab Testing Capabilities for Biologics

PR-M12-18-NI-035
Stem Cells

USRM announces U.S. Stem Cell Clinic Expansion of Products and Services

PR-M12-18-NI-033
FDA Acceptance

FDA Accepts Filing of New Estrogen-free Oral Contraceptive Developed by Exeltis

PR-M12-18-NI-030
FDA Approval

Olympus Spiration® Valve System Is FDA Approved for the Endobronchial Treatment of Emphysema

PR-M12-18-NI-029
Clinical Trial

Prometic to Initiate PBI-4050 Pivotal Phase 3 Clinical Trial in Alström Syndrome

PR-M12-18-NI-028
Appointment

Sartorius Supervisory Board Appoints Two New Executive Board Members

PR-M12-18-NI-027
License Agreement

Ablexis Announces Licensing Agreement with Allogene Therapeutics

PR-M12-18-NI-026
Leukemia

Astellas Presents Updated Results from Phase 1 Study of Gilteritinib Plus Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)

PR-M12-18-NI-025
Obesity

The Anti-Obesity Drugs Market Will Register a CAGR of Almost 8% by 2023

PR-M12-18-NI-024
Chronic Migraine

Migraine Drugs Market Size Worth $7.8 Billion by 2025 | CAGR: 18.0%: Grand View Research, Inc.

PR-M12-18-NI-023
Probiotics

Hard-Shell Capsule Solutions for Sensitive Compounds: A Focus on Probiotics

PAO-M12-18-CL-002
Clinical Trials

Late-Breaking Clinical Trials Advance Targeted Therapies for Patients with CLL and Multiple Myeloma

PR-M12-18-NI-018
Phase 3

New DARZALEX® (daratumumab) Phase 3 Study Shows Efficacy and Safety Data of Anti-CD38 Monoclonal Antibody in Patients with Newly Diagnosed Multiple Myeloma

PR-M12-18-NI-019
Oncology

IMBRUVICA® (ibrutinib) Combination Regimen Significantly Improved Survival Versus the Chemoimmunotherapy FCR

PR-M12-18-NI-017
Bayer

Cutbacks and Divestitures Planned at Bayer

PAO-M12-18-NI-004
FDA

FDA Gives Novartis Gene Replacement Therapy Application Priority Review

PAO-M12-18-NI-003
Acquisition

GSK Acquires Oncology Company Tesaro

PAO-M12-18-NI-008
Acquisition

Unilever’s Indian Subsidiary to Acquire GSK’s Consumer Nutrition Brands in India

PAO-M12-18-NI-002
Bispecific Antibody

Regeneron’s Bispecific Antibody Candidate Shows Positive Results in Early Clinical Studies

PAO-M12-18-NI-007
Licensing Agreement

Pfizer to License AbbVie’s Humira IP

PAO-M12-18-NI-006
Collaboration Agreement

Cilag GmbH to Collaborate with argenx on New Treatment for AML, MDS

PAO-M12-18-NI-005
Biosimilars

Pfizer’s Rituximab Biosimilar Achieves Positive Study Results

PAO-M12-18-NI-001
Equipment

Steps Ahead: Planning for Future Equipment Surpluses from the Point of Procurement

PAO-M12-18-CL-001
Alzheimer's Disease

Ocular Technology Provides Early Detection of Alzheimer's Disease

PR-M12-18-NI-014
Immunotherapy

Global Cancer Immunotherapy Market 2017-2027 Featuring Leading Players - Pfizer, Merck, Amgen and Roche

PR-M12-18-NI-012
Cystic Fibrosis

Aridis Expands Research Agreement with the Cystic Fibrosis Foundation and is Awarded FDA Expedited Program Designations

PR-M12-18-NI-013
ADC

Ajinomoto Bio-Pharma Services Introduces AJICAP Bioconjugation Technology for ADC Manufacturing

PR-M12-18-NI-010
Market Prediction

The global single-use bioprocessing market is anticipated to reach revenues of approximately $7 billion by 2024

PR-M12-18-NI-009
Stem Cells

Platelets Grown from Stem Cells May be Alternative to Donated Platelets

PR-M12-18-NI-006
FDA Approval

FDA Approves First Biosimilar for Treatment of Adult Patients with Non-Hodgkin's Lymphoma

PR-M12-18-NI-004
Partnership

WuXi Biologics and ABL Bio Enter an Exclusive Development and Clinical Manufacturing Partnership for Multiple Bispecific Antibodies

PR-M12-18-NI-003
Research

Researchers Regrow Hair on Wounded Skin

PR-M12-18-NI-002
Clinical Trial

First Trial Launches to Test Effectiveness of Male Contraceptive Gel

PR-M12-18-NI-001
Capsule

How to Tell If You’re Using a Quality Hard Capsule

PAO-M11-18-CL-001
Market Prediction

The Global Cell Therapy Market Size is Expected to Reach USD 7.92 Billion by 2025

PR-M11-18-NI-106
Probiotics

Probiotic Ingredients Market Worth Over $3 Billion by 2024: Global Market Insights, Inc.

PR-M11-18-NI-103
Respiratory

Theravance Biopharma Announces First Subject Dosed in Phase 1 Clinical Trial of TD-8236, a Novel Inhaled pan-JAK Inhibitor

PR-M11-18-NI-102
Awards

MilliporeSigma Wins Two R&D 100 Awards for Innovation in 2018

PR-M11-18-NI-101
Financing

Antios Therapeutics Raises $25 Million in Oversubscribed Series A Financing to Pursue Hepatitis B Cure

PR-M11-18-NI-100
Acquisition

Interventional Medicine Maker BTG Will Be Purchased by Boston Scientific

PAO-M11-18-NI-030
Clinical Study

Clinical Study Explores the Efficacy of Numerous Ebola Therapies

PAO-M11-18-NI-029
Research

Researchers Discover Potential Cause for Alzheimer’s Disease

PAO-M11-18-NI-028
FDA

First Treatment for Primary Hemophagocytic Lymphohistiocytosis Approved by FDA

PAO-M11-18-NI-027
Facility

WuXi Biologics Breaks Ground on Innovation Center in China

PAO-M11-18-NI-026
FDA Approval

FDA Approves New Bone Cancer Drug

PAO-M11-18-NI-025
CRISPR

CRISPR Used to Edit Genes in Human Embryos

PAO-M11-18-NI-024
Launch

Perrigo Launches Its AB Rated Generic Version of Solaraze® Gel 3%

PR-M11-18-NI-100
Research

Newfound Mechanism May Yield Ways to Counter Mistaken Immune Attack on Body

PR-M11-18-NI-097
Market Prediction

Cannabis Market Worth $39.4 Billion by 2023 - Exclusive Report by MarketsandMarkets™

PR-M11-18-NI-099
Facility

GE Healthcare to Open Biotechnology Manufacturing Center in UK

PR-M11-18-NI-096
3D Printing

3D Systems' Medical Workflow Enables OpHeart's Mission with 3D Printed Anatomical Models for Pediatric Heart Surgeries

PR-M11-18-NI-095
FDA Inspection

Mylan Statement in Response to FDA Warning Letter Relating to Morgantown Plant

PR-M11-18-NI-093
Crohn's Disease

Theravance Biopharma Announces First Patient Dosed in Phase 2 Study of TD-1473 in Patients with Crohn's Disease

PR-M11-18-NI-092
New Facility

Fresenius Leases Space at Enterprise Business Park

PR-M11-18-NI-091
Launch

Astellas Global Health Foundation Launches

PR-M11-18-NI-087
Collaboration

TARGET PharmaSolutions® to Advance Research in NASH and Hepatitis B Through New Collaboration with Gilead Sciences

PR-M11-18-NI-089
Recall

Mylan Initiates Voluntary Nationwide Recall Due to the Detection of Trace Amounts of NDEA

PR-M11-18-NI-087
CRISPR

CRISPR Technology Market Worth $1,715 Million by 2023 - Exclusive Report by MarketsandMarkets™

PR-M11-18-NI-083
Oncology

World Institute of Kimchi: Function-enhanced kimchi inhibits growth of cancer cells

PR-M11-18-NI-081
Positive Opinion

Amgen Receives CHMP Positive Opinion To Expand Use Of BLINCYTO® (Blinatumomab)

PR-M11-18-NI-74
Clinical Trial

Auritec Pharmaceuticals Completes Enrollment for its Sustained-release Depot Tacrolimus Clinical Trial

PR-M11-18-NI-078
Facility

CASI Pharmaceuticals To Build GMP Manufacturing Site In Wuxi, China

PR-M11-18-NI-085
Clinical Trial

Promentis Pharmaceuticals Announces Successful Completion of Phase 1 Studies for SXC-2023 Targeting Novel Glutamatergic Mechanism

PR-M11-18-NI-084
Oncology

New Study Makes Important Step Toward Treatment of Deadly Brain Cancer

PR-M11-18-NI-073
Clinical Trials

Sollis Therapeutics Announces the First Patient Enrolled in a Phase 3 Clinical Trial of Clonidine Micropellet for Sciatica

PR-M11-18-NI-078
Clinical Trials

AIVITA Biomedical Announces Treatment of First Two Patients in Phase 2 Glioblastoma Trial

PR-M11-18-NI-073
Finance

Kodiak Sciences Announces Third Quarter 2018 Financial Results and Recent Business Highlights

PR-M11-18-NI-071
Oncology

Radiotherapy Makes a Comeback

PAO-M11-18-NI-023
Immunotherapy

Patient Weight Can Impact the Effectiveness of Cancer Immunotherapies

PAO-M11-18-NI-022
Clinical Trials

Phase III Study Results for Peanut Allergy Therapy Are a Mixed Bag

PAO-M11-18-NI-021
FDA Approval

Novartis’ Promacta Gets Expanded Use Approval from the FDA

PAO-M11-18-NI-020
Drug Development

EMA Recommends Approval of the First Oral Drug for Sleeping Sickness

PAO-M11-18-NI-019
Pricing

More Price Hikes Coming from Pfizer Next Year

PAO-M11-18-NI-018
Partnership

Immunocore Expands Partnership with Roche

PAO-M11-18-NI-017
Recall

Sandoz Issues Voluntary Recall of Losartan

PAO-M11-18-NI-016
Clinical Results

Theranica Announces Results from Pivotal Study of Device for Treating Acute Migraine

PR-M11-18-NI-066
Clinical Results

BAROnova's TransPyloric Shuttle® (TPS®) Positive Pivotal Trial Data Presented at the 2018 Obesity Week Conference

PR-M11-18-NI-070
Clinical Data

DNAtrix To Present Interim Phase 2 Results of DNX-2401 with Pembrolizumab for Glioblastoma

PR-M11-18-NI-067
Clinical Study

Pulmatrix to Present Results from the Pulmazole (PUR1900) Phase 1/1b Study at 2018 Annual Scientific Meeting

PR-M11-18-NI-063
Oncology

Cervical Cancer Treatment: Cure Is Possible If Patients Receive Brachytherapy

PR-M11-18-NI-065
Acquisition

Synteract Acquires Pediatric CRO KinderPharm to Further Strengthen its Pediatric Center of Development

PR-M11-18-NI-064
Research

New Finding Adds Proof Microbes are at Alzheimer's "Crime Scene," Says Dr. Leslie Norins, CEO of Alzheimer's Germ Quest, Inc.

PR-M11-18-NI-062
Drug Development

Published Study: Pycnogenol® Measurably Improved Symptoms Related to Enlarged Prostate Within 60 Days

PR-M11-18-NI-061
License Agreement

Arena Pharmaceuticals and United Therapeutics Announce Global License Agreement for Ralinepag

PR-M11-18-NI-059
Oncology

Patients Launch New Study to Shed Light on EGFR-Positive Lung Cancers

PR-M11-18-NI-060
Innovation

NIH $1.4M Grant Supports Study into Precision Bioelectronic Medicine

PR-M11-18-NI-057
Drug Pricing

Gemini Health and Surescripts Partner to Lower Drug Costs through Prescription Price Transparency at the Point of Prescribing

PR-M11-18-NI-055